Release Date: 2024-03-07

Cancer Diagnosis, Screening, Treatment

Mursel Duzova (Author)

Release Date: 2024-03-07

This chapter delves into various aspects of cancer, covering its diagnosis, screening, and treatment. Beginning with an introduction to the fundamentals of cancer, it presents an overview of cancer epidemiology and statistics, highlighting the prevalence and impact of the disease worldwide. Cancer screening methods are discussed next, emphasizing the importance of early detection in improving [...]

Media Type

  • PDF

Buy from

Price may vary by retailers

Work TypeBook Chapter
Published inOncological Rehabilitation a Handbook for Healthcare Professionals
First Page19
Last Page53
DOIhttps://doi.org/10.69860/nobel.9786053358893.2
ISBN978-605-335-889-3 (PDF)
LanguageENG
Page Count35
Copyright HolderNobel Tıp Kitabevleri
Licensehttps://nobelpub.com/publish-with-us/copyright-and-licensing

This chapter delves into various aspects of cancer, covering its diagnosis, screening, and treatment. Beginning with an introduction to the fundamentals of cancer, it presents an overview of cancer epidemiology and statistics, highlighting the prevalence and impact of the disease worldwide. Cancer screening methods are discussed next, emphasizing the importance of early detection in improving outcomes. The chapter then moves on to clinical assessment and physical examination techniques vital for identifying cancer signs and symptoms. Laboratory tests play a crucial role in cancer diagnosis, with detailed descriptions of various tests used to detect cancer markers. Imaging modalities such as X-rays, CT scans, MRI, and PET scans are also covered, showcasing their significance in visualizing tumors and guiding treatment. Biopsy and histopathological examinations are explained as definitive diagnostic tools, providing microscopic insights into tumor characteristics. The chapter further explores molecular and genetic testing, which offers personalized treatment options based on genetic mutations. In terms of treatment, the chapter outlines different surgical approaches and their indications, alongside discussing potential complications and the role of physical therapy in rehabilitation. Radiation therapy, including external beam radiation therapy and brachytherapy, is elaborated upon, followed by a discussion on managing its side effects through rehabilitation. Chemotherapy agents and their combinations, along with their side effects and related rehabilitation considerations, are detailed. The chapter also covers targeted therapies like monoclonal antibodies and tyrosine kinase inhibitors, emphasizing the importance of rehabilitation in managing these treatments. Lastly, immunotherapy, specifically immune checkpoint inhibitors, is discussed with a focus on the rehabilitation needs of patients undergoing such treatments. Overall, this comprehensive chapter provides a thorough understanding of cancer diagnosis, screening, and treatment modalities, underscoring the importance of rehabilitation in enhancing patient outcomes.

Mursel Duzova (Author)
Selcuk University
https://orcid.org/0000-0003-1036-2593
3After graduating from Çukurova University Faculty of Medicine in 2007, he started his career in medicine. After his graduation, he turned to medical specialization and successfully completed his specialization in Radiation Oncology at Istanbul University Cerrahpaşa Faculty of Medicine in 2015. During this period, he gained experience in the treatment of oncological patients with radiotherapy and took part in many scientific studies. In 2015, he was appointed to Selçuk University Faculty of Medicine as a Radiation Oncology specialist and started his academic career. Here, he took an active role in both clinical practices and academic studies. He made significant contributions by continuing his patient treatment, student education and research activities. In line with his academic success and contributions in 2021, Dr. Lecturer He was promoted to member. During his tenure at Selçuk University, he attended many national and international congresses, closely followed the developments in his field and published scientific articles. In 2024, he continued to progress in his academic career and was entitled to receive the title of Associate Professor. He currently works as an Associate Professor in the Department of Radiation Oncology at Selçuk University Faculty of Medicine and continues to provide the best treatment service to his patients and to train the radiation oncologists of the future. Additionally, he continues to contribute to the field of oncology by conducting scientific research.

  • Hanahan, D., & Weinberg, R. A. (2011). Hallmarks of cancer: The next generation. Cell, 144(5), 646-674.

  • Hanahan, D. (2022). Hallmarks of cancer: New dimensions. Cancer Discovery, 12(1), 31-46.

  • DePinho, R. A. (2020). The age of cancer. Nature, 596(7872), 8-9.

  • Massagué, J. (2021). TGFβ in Cancer. Cell, 134(2), 215-230.

  • Kinzler, K. W., & Vogelstein, B. (2015). Cancer genes and the pathways they control. In The Biology of Cancer (2nd ed.). Garland Science.

  • Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018). Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians, 68(6), 394-424.

  • Ferlay, J., Ervik, M., Lam, F., Colombet, M., Mery, L., Pineros, M., ... & Bray, F. (2021). Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer. Retrieved from https://gco.iarc.fr/today

  • Siegel, R. L., Miller, K. D., & Jemal, A. (2020). Cancer statistics, 2020. CA: A Cancer Journal for Clinicians, 70(1), 7-30.

  • Smith, R. A., Andrews, K. S., Brooks, D., Fedewa, S. A., Manassaram-Baptiste, D., Saslow, D., & Brawley, O. W. (2017). Cancer screening in the United States, 2017: A review of current American Cancer Society guidelines and current issues in cancer screening. CA: A Cancer Journal for Clinicians, 67(2), 100-121.

  • Ronco, G., Dillner, J., Elfström, K. M., Tunesi, S., Snijders, P. J., Arbyn, M., ... & Segnan, N. (2014).

  • Efficacy of HPV-based screening for prevention of invasive cervical cancer: Follow-up of four European randomized controlled trials. The Lancet, 383(9916), 524-532.

  • Zauber, A. G., Winawer, S. J., O’Brien, M. J., Lansdorp-Vogelaar, I., van Ballegooijen, M., Hankey, B. F., ... & Kuntz, K. M. (2012). Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths. The New England Journal of Medicine, 366(8), 687-696.

  • National Lung Screening Trial Research Team. (2011). Reduced lung-cancer mortality with lowdose computed tomographic screening. The New England Journal of Medicine, 365(5), 395- 409.

  • Schröder, F. H., Hugosson, J., Roobol, M. J., Tammela, T. L., Zappa, M., Nelen, V., ... & Auvinen, A. (2014). Screening and prostate cancer mortality: Results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up. The Lancet, 384(9959), 2027-2035.

  • Win, A. K., et al. (2017). Risks of colorectal and other cancers after endometrial cancer for women with Lynch syndrome. Journal of the National Cancer Institute, 109(4), djw236.

  • Torre, L. A., et al. (2015). Global cancer statistics, 2012. CA: A Cancer Journal for Clinicians, 65(2), 87-108.

  • Saslow, D., et al. (2016). Breast cancer screening for women at average risk: 2015 guideline update from the American Cancer Society. JAMA, 314(15), 1599-1614.

  • Louis, D. N., et al. (2016). The 2016 World Health Organization classification of tumors of the central nervous system: a summary. Acta Neuropathologica, 131(6), 803-820.

  • Mandelker, D., et al. (2018). Germline-focussed analysis of tumour-only sequencing: recommendations from the ESMO Precision Medicine Working Group. Annals of Oncology, 30(2), 122-127.

  • Hayes, J. H., et al. (2018). Prostate cancer screening. Annals of Internal Medicine, 168(5), ITC33- ITC48.

  • Edge, S. B., & Compton, C. C. (2010). The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Annals of Surgical Oncology, 17(6), 1471-1474.

  • Prades, J., et al. (2015). Multidisciplinary teams in cancer care: a systematic review of the literature. The Quarterly Journal of Medicine, 108(6), 451-460.

  • Hoffbrand, A. V., Moss, P. A. H., & Pettit, J. E. (2016). Hoffbrand’s Essential Haematology (7th ed.). John Wiley & Sons

  • Hayes, J. H., & Barry, M. J. (2014). Screening for prostate cancer with the prostate-specific antigen test: a review of current evidence. JAMA, 311(11), 1143-1149.

  • Jacobs, I., & Menon, U. (2016). Progress and challenges in screening for early detection of ovarian cancer. Molecular & Cellular Proteomics, 15(12), 3558-3568.

  • Locker, G. Y., et al. (2006). ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer. Journal of Clinical Oncology, 24(33), 5313-5327.

  • Lynch, T. J., et al. (2004). Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. New England Journal of Medicine, 350(21), 2129-2139.

  • Lee, E. Y., et al. (2018). Radiography and fluoroscopy. In E. Y. Lee et al. (Eds.), Pediatric Radiology: Practical Imaging Evaluation of Infants and Children (2nd ed.). Elsevier.

  • Sidhu, P. S., et al. (2018). The EFSUMB guidelines and recommendations for the clinical practice of contrast-enhanced ultrasound (CEUS) in non-hepatic applications: update 2017 (long version). Ultraschall in der Medizin - European Journal of Ultrasound, 39(2), e2-e44.

  • Kang, J., et al. (2019). Computed tomography in oncologic imaging: A primer for radiologists. Journal of Clinical Oncology, 37(22), 1902-1910.

  • Padhani, A. R., et al. (2016). Dynamic contrast-enhanced magnetic resonance imaging in oncology: Current status and future directions. Journal of Clinical Oncology, 35(26), 3179-3185.

  • Antoch, G., et al. (2017). Whole-body PET/MRI: The future in oncological imaging. Clinical Radiology, 72(5), 416-426).

  • Soyer, P., et al. (2017). Imaging-guided percutaneous biopsy of focal liver lesions: How we do it and why we do it. European Radiology, 27(8), 3448-3460.

  • Al-Haddad, M. A., et al. (2017). Performance characteristics of molecular (DNA) analysis for the diagnosis of mucinous pancreatic cysts. Gastrointestinal Endoscopy, 85(1), 81-86.

  • Elston, C. W., & Ellis, I. O. (1991). Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology, 19(5), 403-410.

  • Dvorak, H. F. (2015). Tumors: wounds that do not heal-redux. Cancer Immunology Research, 3(1), 1-11.

  • Ferlay, J., et al. (2019). The global cancer observatory: A new approach to worldwide cancer data. Cancer Epidemiology, 60, 5-7.

  • Slamon, D. J., et al. (2001). Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. New England Journal of Medicine, 344(11), 783-792.

  • Siravegna, G., et al. (2017). Liquid biopsy in cancer patients: The promise of next-generation sequencing. Cancer Discovery, 7(6), 586-587.

  • Beltran, H., et al. (2013). Whole-exome sequencing of metastatic cancer and biomarkers of treatment response. JAMA Oncology, 1(4), 466-474.

  • Le Tourneau, C., et al. (2019). Molecularly targeted therapy based on tumour molecular profiling versus conventional therapy for advanced cancer (SHIVA): a multicentre, open-label, proofof-concept, randomised, controlled phase 2 trial. The Lancet Oncology, 16(13), 1324-1334

  • Hoadley, K. A., et al. (2018). Cell-of-origin patterns dominate the molecular classification of 10,000 tumors from 33 types of cancer. Cell, 173(2), 291-304.

  • Fisher, B., et al. (2002). Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. New England Journal of Medicine, 347(16), 1233-1241.

  • Gershenwald, J. E., et al. (2017). Melanoma staging: Evidence-based changes in the American Joint Committee on Cancer eighth edition cancer staging manual. CA: A Cancer Journal for Clinicians, 67(6), 472-492.

  • Parekh, D. J., et al. (2017). Robot-assisted radical prostatectomy versus open radical prostatectomy: A randomized controlled trial. European Urology, 72(2), 215-224.

  • Johnstone, C. S., et al. (2019). Palliative surgery for patients with advanced cancer: Are we on the right track? Annals of Surgery, 269(5), 813-818.

  • Jensen, A. R., et al. (2018). Reconstruction and rehabilitation of head and neck cancer patients. Otolaryngologic Clinics of North America, 51(4), 781-796.

  • Crary, M. A., et al. (2006). Effects of neuromuscular electrical stimulation on oral intake, nutritional status, and quality of life in patients with head and neck cancer: A randomized controlled trial. Head & Neck, 28(4), 311-320.

  • Hermans, M., et al. (2018). Physiotherapy rehabilitation for whiplash associated disorders: A systematic review and meta-analysis. Journal of Orthopaedic & Sports Physical Therapy, 48(3), 182-193.

  • Schmitz, K. H., et al. (2010). American College of Sports Medicine roundtable on exercise guidelines for cancer survivors. Medicine & Science in Sports & Exercise, 42(7), 1409-1426.

  • Dursun, N., et al. (2017). The effect of pelvic floor muscle exercises on urinary incontinence and quality of life in patients with prostate cancer undergoing robotic-assisted radical prostatectomy: A randomized controlled trial. European Journal of Oncology Nursing, 31, 48-54.

  • Grimer, R. J., et al. (2014). The long-term outcomes of limb salvage surgery for extremity soft tissue sarcomas. Bone & Joint Journal, 96(10), 1436-1440.

  • Smith, B. D., et al. (2019). Radiation therapy for the whole breast: Executive summary of an American Society for Radiation Oncology (ASTRO) evidence-based guideline. Practical Radiation Oncology, 9(5), 275-280.

  • Timmerman, R. D., et al. (2010). Stereotactic body radiation therapy for inoperable early stage lung cancer. JAMA, 303(11), 1070-1076. Martinez, A., et al. (2016). Modern brachytherapy. Nature Reviews Clinical Oncology, 13(8), 493- 502.

  • Liauw, S. L., et al. (2018). Comparative effectiveness of adjuvant radiotherapy versus observation in patients with T1/2N0 triple-negative breast cancer: A population-based analysis. Cancer, 124(24), 4673-4685.

  • Bentzen, S. M., et al. (2006). Quantitative analyses of normal tissue effects in the clinic (QUANTEC): An introduction to the scientific issues. International Journal of Radiation Oncology, Biology, Physics, 76(3 Suppl), S3-9.

  • Courneya, K. S., et al. (2007). Effects of aerobic and resistance exercise in breast cancer patients receiving adjuvant chemotherapy: A multicenter randomized controlled trial. Journal of Clinical Oncology, 25(28), 4396-4404.

  • Paskett, E. D., et al. (2012). Systematic review of breast cancer survivorship care for lymphedema: A state-of-the-science review. Journal of Cancer Survivorship, 6(4), 373-386.

  • Carnaby-Mann, G., & Crary, M. A. (2008). Pill swallowing by adults with dysphagia. Archives of Otolaryngology–Head & Neck Surgery, 134(2), 178-181.

  • Wong, R. K., et al. (2015). Radiation therapy for the management of cancer-related pain. Journal of Palliative Medicine, 18(2), 165-172.

  • Mitchell, A. J., et al. (2013). Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: A meta-analysis of 94 interview-based studies. The Lancet Oncology, 11(2), 160-174.

  • Longley, D. B., et al. (2003). The causes and consequences of cancer drug resistance: From mechanisms to clinical implications. European Journal of Cancer, 39(6), 278-291.

  • Baker, E. K., et al. (2019). Chemotherapy-induced cognitive impairments: A systematic review of the animal literature. Neuroscience & Biobehavioral Reviews, 102, 382-399.

  • Jones, L. W., et al. (2019). Exercise and cancer-related fatigue. US Oncology Review, 8(1), 27-31.

  • Druker, B. J., et al. (2001). Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia. New England Journal of Medicine, 344(14), 1031-1037.

  • Hodi, F. S., et al. (2010). Improved survival with ipilimumab in patients with metastatic melanoma. New England Journal of Medicine, 363(8), 711-723.

  • Postow, M. A., et al. (2018). Managing immune checkpoint-blocking antibody side effects. American Society of Clinical Oncology Educational Book, 38, 76-83.

onix_3.0::thothThoth ONIX 3.0
onix_3.0::project_museProject MUSE ONIX 3.0
onix_3.0::oapenOAPEN ONIX 3.0
onix_3.0::jstorJSTOR ONIX 3.0
onix_3.0::google_booksGoogle Books ONIX 3.0
onix_3.0::overdriveOverDrive ONIX 3.0
onix_2.1::ebsco_hostEBSCO Host ONIX 2.1
csv::thothThoth CSV
json::thothThoth JSON
kbart::oclcOCLC KBART
bibtex::thothThoth BibTeX
doideposit::crossrefCrossRef DOI deposit
onix_2.1::proquest_ebraryProQuest Ebrary ONIX 2.1
marc21record::thothThoth MARC 21 Record
marc21markup::thothThoth MARC 21 Markup
marc21xml::thothThoth MARC 21 XML

Share This Chapter!